Estimation of true serum thyroglobulin concentration using simultaneous measurement of serum antithyroglobulin antibody

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Ahn, Byeong Cheol ^a   Lee, Won Kee ^a   Jeong, Shin Young ^a   Lee, Sang Woo ^a   Lee, Jaetae ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN; THYROGLOBULIN ANTIBODY;

ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; DIFFERENTIATED THYROID CANCER; HUMAN; IMMUNORADIOMETRIC ASSAY; MATHEMATICAL ANALYSIS; PREDICTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REPRODUCIBILITY; THYROGLOBULIN BLOOD LEVEL;

EID: 84877301601     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/210639     Document Type: Article

References (23)

1. Cooper D. S., Doherty G. M., Haugen B. R., Kloos R. T., Lee S. L., Mandel S. J., Mazzaferri E. L., McIver B., Pacini F., Schlumberger M., Sherman S. I., Steward D. L., Tuttle R. M., Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009 19 11 1167 1214 2-s2.0-70449370231 10.1089/thy.2009.0110
2. Reiners C., Dietlein M., Luster M., Radio-iodine therapy in differentiated thyroid cancer: indications and procedures. Best Practice and Research: Clinical Endocrinology and Metabolism 2008 22 6 989 1007 2-s2.0-56849086574 10.1016/j.beem.2008.09.013
3. Ahn B., Seo J., Bae J., Effects of anti-thyroglobulin antibody on the measurement of thyroglobulin: differences between immunoradiometric assay kits available. Korean Journal of Nuclear Medicine 2005 39 4 252 256
4. Ahn B., Bae J., Jeong S., Influence of anti-thyroglobulin antibody on the measurement of thyroglobulin using the immunoradiometric assay. Journal of Korean Society of Endocrinology 2004 19 1 42 47
5. Stanojević M., Savin S., Cvejić D., Dukić A., Simonović S. Z., Correlation of thyroglobulin concentrations measured by radioimmunoassay and immunoradiometric assay and the influence of thyroglobulin antibody. Journal of Immunoassay and Immunochemistry 2009 30 2 197 207 2-s2.0-65549094194 10.1080/15321810902782897
6. Spencer C. A., LoPresti J. S., Technology Insight: measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer. Nature Clinical Practice Endocrinology and Metabolism 2008 4 4 223 233 2-s2.0-41149095035 10.1038/ncpendmet0757 (Pubitemid 351430907)
7. Aras G., Gültekin S. S., Küçük N. Ö., Genç Y., Is thyroglobulin the stronger indicator for progressive disease than the other conventional factors in same age patient groups with differentiated thyroid cancer? Nuclear Medicine Communications 2007 28 12 907 913 2-s2.0-37349050302 10.1097/MNM.0b013e3282f1ac6c (Pubitemid 350306782)
8. Hoofnagle A. N., Wener M. H., The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. Journal of Immunological Methods 2009 347 1-2 3 11 2-s2.0-67650432879 10.1016/j.jim.2009.06.003
9. Locsei Z., Szabolcs I., Rácz K., Kovács G. L., Horváth D., Toldy E., Serum thyroglobulin antibody levels within or near to the reference range may interfere with thyroglobulin measurement. Biochemical Medicine 2012 22 3 365 370
10. Spencer C., Fatemi S., Singer P., Nicoloff J., Lopresti J., Serum basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer. Thyroid 2010 20 6 587 595 2-s2.0-77953932599 10.1089/thy.2009.0338
11. Mazzaferri E. L., Kloos R. T., Current approaches to primary therapy for papillary and follicular thyroid cancer. The Journal of Clinical Endocrinology & Metabolism 2001 86 4 1447 1463 2-s2.0-0035318655 10.1210/jc.86.4.1447 (Pubitemid 32374886)
12. Leboulleux S., Schroeder P. R., Busaidy N. L., Auperin A., Corone C., Jacene H. A., Ewertz M. E., Bournaud C., Wahl R. L., Sherman S. I., Ladenson P. W., Schlumberger M., Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer. The Journal of Clinical Endocrinology & Metabolism 2009 94 4 1310 1316 2-s2.0-65249111705 10.1210/jc.2008-1747
13. Spencer C. A., Takeuchi M., Kazarosyan M., Wang C. C., Guttler R. B., Singer P. A., Fatemi S., Lopresti J. S., Nicoloff J. T., Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. The Journal of Clinical Endocrinology & Metabolism 1998 83 4 1121 1127 2-s2.0-0031791032 10.1210/jc.83.4.1121 (Pubitemid 28496379)
14. Madureira D., Prazeres S., Pedro M. S., Pereira T., Font A. P., Bugalho M. J., In vitro assays to test the interference of anti-thyroglobulin antibodies on thyroglobulin measurement. Endocrine 2008 33 1 40 44 2-s2.0-46149098430 10.1007/s12020-008-9053-2
15. Chiovato L., Latrofa F., Braverman L. E., Pacini F., Capezzone M., Masserini L., Grasso L., Pinchera A., Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Annals of Internal Medicine 2003 139 5 346 351 2-s2.0-0141497513
16. Spencer C. A., Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). The Journal of Clinical Endocrinology & Metabolism 2011 96 3615 3627 10.1210/jc.2011-1740
17. Seo J. H., Lee S. W., Ahn B. C., Lee J., Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using 18F-FDG PET/CT. Clinical Endocrinology 2010 72 4 558 563 2-s2.0-77749301418 10.1111/j.1365-2265.2009. 03693.x
18. Gao Y., Yuan Z., Yu Y., Lu H., Mutual interference between serum thyroglobulin and antithyroglobulin antibody in an automated chemiluminescent immunoassay. Clinical Biochemistry 2007 40 9-10 735 738 2-s2.0-34249683915 10.1016/j.clinbiochem.2007.03.010 (Pubitemid 46829077)
19. Spencer C., Petrovic I., Fatemi S., Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. The Journal of Clinical Endocrinology & Metabolism 2011 96 5 1283 1291 2-s2.0-79955653371 10.1210/jc.2010-2762
20. Berger F., Friedrich U., Knesewitsch P., Hahn K., Diagnostic 131I whole-body scintigraphy 1 year after thyroablative therapy in patients with differentiated thyroid cancer: correlation of results to the individual risk profile and long-term follow-up. European Journal of Nuclear Medicine and Molecular Imaging 2011 38 3 451 458 2-s2.0-79953753720 10.1007/s00259-010-1657-0
21. Latrofa F., Ricci D., Montanelli L., Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin. The Journal of Clinical Endocrinology & Metabolism 2012 97 7 2380 2387 10.1210/jc.2011-2812
22. Latrofa F., Ricci D., Grasso L., Vitti P., Masserini L., Basolo F., Ugolini C., Mascia G., Lucacchini A., Pinchera A., Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies. The Journal of Clinical Endocrinology & Metabolism 2008 93 2 591 596 2-s2.0-39049111167 10.1210/jc.2007-1199 (Pubitemid 351246677)
23. Latrofa F., Ricci D., Montanelli L., Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. The Journal of Clinical Endocrinology & Metabolism 2012 97 11 3974 3982 10.1210/jc.2012-2406